Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of TRS01 vs prednisolone acetate in non-infectious anterior uveitis
2021-005120-38Phase 3Completed
- Sponsor
- Tarsier Pharma
- Start
- Dec 2021
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dazdotuftide in anterior uveitis (AAU) and Inflammatory Glaucoma (2 arms), sponsored by Tarsier Pharma. Primary endpoint: Primary efficacy and safety endpoint. Started Dec 2021; status: completed.
02
Drugs
dazdotuftide
03
Conditions
anterior uveitis (AAU)Inflammatory Glaucoma
Beyond the preview
Go deeper on 2021-005120-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-005120-38.